Author:
Kubala Marta Helena,DeClerck Yves Albert
Publisher
Springer Science and Business Media LLC
Reference103 articles.
1. Unkeless, J. C., Tobia, A., Ossowski, L., Quigley, J. P., Rifkin, D. B., & Reich, E. (1973). Enzymatic function associated with transformation of fibroblasts by oncogenic viruses. 1. Chick-embryo fibroblast cultures transformed by avian rna tumor-viruses. Journal of Experimental Medicine, 137(1), 85–111.
2. Duffy, M. J., Reilly, D., McDermott, E., O'Higgins, N., Fennelly, J. J., & Andreasen, P. A. (1994). Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer. Cancer, 74(8), 2276–2280. https://doi.org/10.1002/1097-0142(19941015)74:8<2276::aid-cncr2820740811>3.0.co;2-7.
3. Duggan, C., Maguire, T., McDermott, E., OHiggins, N., Fennelly, J. J., & Duffy, M. J. (1995). Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int.J.Cancer, 61, 597–600.
4. Grondahl-Hansen, J., Peters, H. A., van Putten, W. L., Look, M. P., Pappot, H., Ronne, E., et al. (1995). Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Clinical Cancer Research, 1(10), 1079–1087.
5. Annecke, K., Schmitt, M., Euler, U., Zerm, M., Paepke, D., Paepke, S., et al. (2008). uPA and PAI-1 in breast cancer: review of their clinical utility and current validation in the prospective NNBC-3 trial. Advances in Clinical Chemistry, 45(45), 31–45.
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献